Correlation Between Unicycive Therapeutics and Silence Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Silence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Silence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Silence Therapeutics PLC, you can compare the effects of market volatilities on Unicycive Therapeutics and Silence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Silence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Silence Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Silence Therapeutics
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and Silence is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Silence Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silence Therapeutics PLC and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Silence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silence Therapeutics PLC has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Silence Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Silence Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.56 times more return on investment than Silence Therapeutics. However, Unicycive Therapeutics is 1.79 times less risky than Silence Therapeutics. It trades about 0.38 of its potential returns per unit of risk. Silence Therapeutics PLC is currently generating about -0.35 per unit of risk. If you would invest 53.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 27.00 from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Silence Therapeutics PLC
Performance |
| Timeline |
| Unicycive Therapeutics |
| Silence Therapeutics PLC |
Unicycive Therapeutics and Silence Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Silence Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Silence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Silence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will offset losses from the drop in Silence Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Silence Therapeutics vs. Cidara Therapeutics | Silence Therapeutics vs. Applied Therapeutics | Silence Therapeutics vs. CytomX Therapeutics | Silence Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |